Berglund G, Lennon C, Badu P, Berglund J, Pager C
Microorganisms. 2024; 12(7).
PMID: 39065267
PMC: 11278784.
DOI: 10.3390/microorganisms12071499.
Neahring L, Cho N, He Y, Liu G, Fernandes J, Rux C
J Cell Biol. 2024; 223(9).
PMID: 38869473
PMC: 11176257.
DOI: 10.1083/jcb.202312046.
Berglund G, Lennon C, Badu P, Berglund J, Pager C
bioRxiv. 2024; .
PMID: 38826459
PMC: 11142252.
DOI: 10.1101/2024.05.25.595842.
Zhuang R, Liu H
Discov Oncol. 2024; 15(1):83.
PMID: 38514510
PMC: 10957832.
DOI: 10.1007/s12672-024-00937-x.
Neahring L, He Y, Cho N, Liu G, Fernandes J, Rux C
bioRxiv. 2024; .
PMID: 38405786
PMC: 10888964.
DOI: 10.1101/2023.12.10.570990.
Whole Transcriptome Analysis Reveals the Global Molecular Responses of mRNAs, lncRNAs, miRNAs, circRNAs, and Their ceRNA Networks to Salinity Stress in Hong Kong Oysters, Crassostrea hongkongensis.
Ibrahim S, Yang C, Yue C, Song X, Deng Y, Li Q
Mar Biotechnol (NY). 2023; 25(4):624-641.
PMID: 37493868
DOI: 10.1007/s10126-023-10234-3.
Diagnostic biomarker KIF23 is associated with immune infiltration and immunotherapy response in gastric cancer.
Bai M, Liu X
Front Oncol. 2023; 13:1191009.
PMID: 37483517
PMC: 10361780.
DOI: 10.3389/fonc.2023.1191009.
Centralspindlin-mediated transport of RhoGEF positions the cleavage plane for cytokinesis.
Warecki B, Tao L
Sci Signal. 2023; 16(792):eadh0601.
PMID: 37402224
PMC: 10501416.
DOI: 10.1126/scisignal.adh0601.
Kinesin family member 23 knockdown inhibits cell proliferation and epithelial-mesenchymal transition in esophageal carcinoma by inactivating the Wnt/β-catenin pathway.
Xu Q, Li X, Li Y, Yu J, Yang A
Funct Integr Genomics. 2023; 23(2):154.
PMID: 37162618
DOI: 10.1007/s10142-023-01088-y.
Single-motor and multi-motor motility properties of kinesin-6 family members.
Poulos A, Budaitis B, Verhey K
Biol Open. 2022; 11(10).
PMID: 36178151
PMC: 9581516.
DOI: 10.1242/bio.059533.
Pathogenic mutations in the chromokinesin KIF22 disrupt anaphase chromosome segregation.
Thompson A, Blackburn P, Arons N, Stevens S, Babovic-Vuksanovic D, Lian J
Elife. 2022; 11.
PMID: 35730929
PMC: 9302971.
DOI: 10.7554/eLife.78653.
Systematic Pan-Cancer Analysis of KIF23 and a Prediction Model Based on KIF23 in Clear Cell Renal Cell Carcinoma (ccRCC).
Bai X, Cao Y, Yan X, Tuoheti K, Du G, Chen Z
Pharmgenomics Pers Med. 2022; 14:1717-1729.
PMID: 35002290
PMC: 8725058.
DOI: 10.2147/PGPM.S337695.
Trim9 and Klp61F promote polymerization of new dendritic microtubules along parallel microtubules.
Feng C, Cleary J, Kothe G, Stone M, Weiner A, Hertzler J
J Cell Sci. 2021; 134(11).
PMID: 34096607
PMC: 8214762.
DOI: 10.1242/jcs.258437.
Mutation and Copy Number Alterations Analysis of KIF23 in Glioma.
Zhao Z, Wang Z, Bao Z, Gao W, Zhang Y, Ruan C
Front Genet. 2021; 12:646929.
PMID: 34017355
PMC: 8129563.
DOI: 10.3389/fgene.2021.646929.
Microtubule-sliding modules based on kinesins EG5 and PRC1-dependent KIF4A drive human spindle elongation.
Vukusic K, Ponjavic I, Buda R, Risteski P, Tolic I
Dev Cell. 2021; 56(9):1253-1267.e10.
PMID: 33910056
PMC: 8098747.
DOI: 10.1016/j.devcel.2021.04.005.
Anaphase B: Long-standing models meet new concepts.
Vukusic K, Tolic I
Semin Cell Dev Biol. 2021; 117:127-139.
PMID: 33849764
PMC: 8406420.
DOI: 10.1016/j.semcdb.2021.03.023.
Aberrant KIF23 expression is associated with adverse clinical outcome and promotes cellular malignant behavior through the Wnt/β-catenin signaling pathway in Colorectal Cancer.
Ji Z, Mi A, Li M, Li Q, Qin C
J Cancer. 2021; 12(7):2030-2040.
PMID: 33754001
PMC: 7974518.
DOI: 10.7150/jca.51565.
Identification of potential markers for differentiating epithelial ovarian cancer from ovarian low malignant potential tumors through integrated bioinformatics analysis.
Hao W, Zhao H, Li Z, Li J, Guo J, Chen Q
J Ovarian Res. 2021; 14(1):46.
PMID: 33726773
PMC: 7968266.
DOI: 10.1186/s13048-021-00794-0.
KIF23 enhances cell proliferation in pancreatic ductal adenocarcinoma and is a potent therapeutic target.
Gao C, Ren J, Yu J, Li S, Guo X, Zhou Y
Ann Transl Med. 2020; 8(21):1394.
PMID: 33313139
PMC: 7723550.
DOI: 10.21037/atm-20-1970.
KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.
Terribas E, Fernandez M, Mazuelas H, Fernandez-Rodriguez J, Biayna J, Blanco I
Neurooncol Adv. 2020; 2(Suppl 1):i62-i74.
PMID: 32642733
PMC: 7317059.
DOI: 10.1093/noajnl/vdz061.